Orbera365 Intragastric Balloon System (Abbreviated as'Orbera365')
← catalyst calendarNCT07195708 · readout in 680 d
Sponsored by Boston Scientific Corporation (industry) · BSX — their whole pipeline →.
Phase
Not applicable
Status
Recruiting
Study type
Interventional
Design
Randomized · Single · Treatment
Enrollment
144estimated
Sites
1
Country
China
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2026-06-03 | actual | When the study began enrolling |
| Primary completion | 2028-06-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2028-12-31 | estimated | The whole study's end, after follow-up |
| First posted | 2025-09-29 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-07-29 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Weight Loss
Intervention
- Device: Treatment group
Primary outcomes
what the primary-completion date above is the date OF%TBWL (Defined as the percentage of total body weight loss)
measured At 12 months after the intervention
The response rate at the 12th month after the intervention
measured At 12 months after the intervention
Permalink · BSX's whole pipeline · Catalyst calendar · Every registered study · What changed